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Diagnosis of Human Leptospirosis 
in a Clinical Setting: Real-Time PCR 
High Resolution Melting Analysis 
for Detection of Leptospira at the 
Onset of Disease
Lisa M. Esteves1, Sara M. Bulhões1, Claudia C. Branco  1,2,3, Teresa Carreira4, Maria L. Vieira4, 
Maria Gomes-Solecki  5 & Luisa Mota-Vieira  1,2,3
Currently, direct detection of Leptospira can be done in clinical laboratories by conventional and by 
real-time PCR (qRT-PCR). We tested a biobank of paired samples of serum and urine from the same 
patient (202 patients) presenting at the hospital in an area endemic for leptospirosis using qRT-PCR 
followed by high resolution melting (HRM) analysis. The results were compared with those obtained by 
conventional nested PCR and with the serologic gold standard microscopic agglutination test (MAT). 
Differences were resolved by sequencing. qRT-PCR-HRM was positive for 46 of the 202 patients (22.7%, 
accuracy 100%) which is consistent with known prevalence of leptospirosis in the Azores. MAT results 
were positive for 3 of the 46 patients (6.5%). Analysis of paired samples allowed us to identify the illness 
point at which patients presented at the hospital: onset, dissemination or excretion. The melting curve 
analysis of Leptospira species revealed that 60.9% (28/46) of patients were infected with L. interrogans 
and 39.1% (18/46) were infected with L. borgpetersenii, both endemic to the Azores. We validated the 
use of qRT-PCR-HRM for diagnosis of leptospirosis and for identification of the Leptospira species at the 
earliest onset of infection in a clinical setting, in less than 2 hours.
Leptospirosis is a worldwide zoonotic and neglected infectious disease caused by pathogenic bacteria of the 
Leptospira genus from the family Leptospiraceae1. This disease is known for its endemicity mainly in countries 
with a humid tropical or subtropical climate2. The infection is associated with a variety of clinical manifestations, 
ranging from flu-like symptoms to multiple organ failure and death3. Symptoms of leptospirosis are frequently 
mistaken for other causes of acute febrile syndrome, such as dengue, hepatitis and malaria, depending on overlap 
of endemic geographic areas. The lack of pathognomonic signs of leptospirosis means that diagnosis is tentatively 
based on evaluation of fever and myalgia in patients presenting at the hospital in areas of endemicity, and it is 
rarely confirmed in most parts of the world due to lack of affordable diagnostic assays. As a result, laboratory 
support is essential.
Current techniques to detect Leptospira evolved from conventional to real-time PCR (qRT-PCR)3. An emerg-
ing technique for clinical diagnosis is high resolution melting (HRM) analysis. HRM uses affordable SYBR green 
chemistries and is performed with a real-time PCR instrument immediately after PCR; its underlying princi-
ple is the generation of different melting curve profiles due to sequence variations in double-stranded DNA4. 
Advantages of this method include a rapid turn-around time (less than 2 hr), a closed-tube format that signifi-
cantly reduces contamination risk, high sensitivity and specificity, low cost and, unlike other methods, no sample 
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processing or separations after PCR5. Furthermore, HRM is a non-damaging method that enables the subsequent 
analysis of the sample by other methods, such as DNA sequencing or gel electrophoresis6.
HRM has been used for detection of oncogene mutations7, human malaria diagnosis8, species differentia-
tion and genotyping within microbial species9. For leptospirosis, several studies have described HRM for typing 
Leptospira strains at the species and subspecies levels10–13, mainly from Leptospira culture. HRM can accurately 
discriminate L. interrogans, L. kirschneri, L. borgpetersenii and L. mayottensis with a specificity and reproducibil-
ity of 100%12. In other studies, HRM has been used to establish proof of principle assays for direct detection of 
Leptospira in human samples14–16. In a clinical context, qRT-PCR TaqMan and qRT-PCR-HRM has been used 
for diagnosis of leptospirosis using blood and/or urine samples17–22. However, none of these studies used paired 
human biological samples.
The aim of the present work was to implement a diagnostic assay for human leptospirosis capable of providing 
timely laboratory results on the same day the patient is seen at the emergency room of the hospital. To address 
this, we used a robust biobank of paired serum and urine samples collected from febrile patients at admission at 
the emergency room and evaluated the accuracy of qRT-PCR-HRM analysis as a clinical diagnostic tool for direct 
detection of Leptospira in the very early stages of human leptospirosis.
Methods
Ethical considerations. The present study followed international ethical guidelines and was evaluated and 
approved (Ref. HDES/CES/159/2009) by the Health Ethics Committee of the Hospital of Divino Espírito Santo of 
Ponta Delgada (HDES). The analysis of retrospective samples (serum and urine) from patients suspected of hav-
ing leptospirosis was exempted from the need to obtain informed consent under the regulations of the Portuguese 
Data Protection Commission – law 12/2005 article 19, number 6 (https://www.cnpd.pt/bin/orientacoes/DEL227-
2007-ESTUDOS-CLINICOS.pdf, accessed February 22, 2017).
Study design. A total of 202 patients were investigated from January 2015 to June 2016 (Supplementary 
Table S1). Serum and urine were collected in sterile biological containers and processed for molecular detection/
confirmation of Leptospira spp. We centrifuged all sera and urine samples at 2000 rpm for 10 minutes. Bacterial 
DNA was automatically extracted from 400 µl of independent samples of serum (S1 and S2) and urine (U1 and 
U2) from each patient using the BioRobot EZ1 Advanced System (Qiagen). A total of 808 samples were processed.
Reference molecular test (conventional nested PCR). Conventional nested PCR was con-
sidered the reference standard for Leptospira spp. DNA detection in the present study. After auto-
matic bacterial DNA extraction, the rrs (16S rRNA) gene was amplified as previously described23,24 by 
conventional nested PCR in a Biometra® T-Gradient thermal cycler. We used two primer sets: forward-A 
5′-GGCGGCGCGTCTTAAACATG-3′ and reverse-B 5′-TTCCCCCCATTGAGCAAGATT-3′ for the first PCR; 
nested-A 5′-TGCAAGTCAAGCGGAGTAGC-3′ and nested-B 5′-TTCTTAACTGCTGCCTCCCG-3′ for the 
nested PCR. The first PCR reaction contained 5 μl of bacterial DNA, 10 μM primers A and B, 100 μM dNTPs 
(Promega), 25 nM MgCl2 (Qiagen), 1X Q-Solution (Qiagen), 1X buffer (Qiagen), 5 U of HotStart Taq (Qiagen) 
and RNase-free water to a final volume of 50 μl. The PCR programme started with an enzyme activation step 
at 95 °C for 15 minutes; proceeded with 30 cycles of 94 °C for 1 minute, 63 °C for 1 minute and 72 °C for 1 min-
ute; and ended with a final extension step at 72 °C for 10 minutes. The nested PCR (2nd round) used 5 μl of the 
first-round PCR product and 10 μM nested-A and nested-B primers. The first cycle consisted of denaturation at 
95 °C for 15 minutes, followed by 30 cycles of denaturation at 94 °C for 1 minute, primer annealing at 63 °C for 
1 minute, and extension at 72 °C for 1 minute, with an additional step at 72 °C for 10 minutes at the end, resulting 
in a 292 bp fragment. Amplified Leptospira DNA was visualized in an UV transilluminator instrument (BioRad) 
after agarose gel electrophoresis (3%). A patient was defined as having a laboratory-confirmed case of leptospiro-
sis when Leptospira DNA was detected in at least one serum (S1 or S2) or urine (U1 or U2) sample.
Real-Time PCR High Resolution Melting (qRT-PCR-HRM) analysis. Primer pairs for qRT-PCR-HRM 
analysis were chosen according to the results obtained by Naze et al.12. We used the following LFB1 F/R and G1/G2 
primers to amplify the lfb1 and secY genes, respectively: LFB1-F 5′-CATTCATGTTTCGAATCATTTCAAA-3′ 
and LFB1-R 5′-GGCCCAAGTTCCTTCTAAAAG-3′, and G1 5′-CTGAATCGCTGTATAAAAGT-3′ and G2 
5′-GGAAAACAAATGGTCGGAAG-3′. The 15 μl reactions contained 7.5 μl of 2X Type-it HRM master mix 
(Qiagen), 0.7 μM final concentration of each primer (TibMolBiol), 3.75 μl of extracted bacterial DNA, and 
RNase-free water to a final volume of 15 μl. We performed the following amplification protocol in the 7500 Fast 
Real-Time PCR instrument (Applied Biosystems): denaturation at 95 °C for 5 minutes, followed by 45 cycles of 
95 °C for 10 seconds, 55 °C for 30 seconds, and 72 °C for 10 seconds. These conditions were used for both primer 
sets. After PCR cycling, the samples were heated from 70 °C to 95 °C with continuous data acquisition.
We used six pathogenic Leptospira reference cultures provided by the Portuguese Reference Laboratory for 
Leptospirosis (at the Instituto de Higiene e Medicina Tropical, IHMT, of the Universidade Nova de Lisboa) as 
positive controls: 4 strains belonging to L. interrogans serogroup (sg) Icterohaemorrhagiae, L. borgpetersenii sg 
Ballum, L. kirschneri sg Cynopteri and L. noguchii sg Panama and 2 human Azorean isolates4 belonging to L. inter-
rogans serovar (sv) Copenhageni of Icterohaemorrhagiae sg (human isolate 1) and L. borgpetersenii sv Arborea 
of Ballum sg (human isolate 6). Melting curve plots were generated and analysed using High Resolution Melt 
software v3.0.1 (Applied Biosystems) to determine average melting temperature (Tm) for each Leptospira spp.
qRT-PCR-HRM benchmarking confirmation by Sanger sequencing. To validate the qRT-PCR-HRM 
analysis, we selected 18 biological specimens (13 serum and 5 urine samples) from laboratory-confirmed lepto-
spirosis patients, including the sample positive by nested PCR and negative by qRT-PCR-HRM analysis. As refer-
ence DNA sequences, we used two Leptospira spp. (L. interrogans sg Icterohaemorrhagiae and L. borgpetersenii sg 
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Ballum) and two human isolates. Amplified DNA products of Leptospira obtained by nested PCR were purified 
using the QIAquick PCR Purification Kit (Qiagen) according to the manufacturer’s instructions. Sequencing was 
performed using the nested-A and nested-B primer pair with the BigDye Terminator v1.1 cycle sequencing kit 
(Applied Biosystems) under the following conditions: 2 μl of ready reaction mix, 4 μl of BigDye sequencing buffer, 
3.2 pmol of each primer pair, 7 ng of DNA, and RNase-free water to a final reaction volume of 20 μl. The cycling 
programme included an initial denaturation step at 96 °C for 1 minute, followed by 25 cycles of 96 °C for 10 sec-
onds, 50 °C for 5 seconds and 60 °C for 4 minutes, in a GeneAmp® PCR System 2700 (Applied Biosystems). The 
sequencing products were purified with a BigDye XTerminator® Purification Kit (Applied Biosystems) and sep-
arated by capillary electrophoresis in an automated sequencer (ABI 3130 Genetic Analyzer, Applied Biosystems) 
with a 36 cm capillary and POP-7™ polymer according to the manufacturer’s instructions. Data were analysed with 
Sequencing Analysis software v5.3.1 (Applied Biosystems). Sequences were aligned using Bioedit™ software v7.0.0.
Microscopic agglutination test (MAT). A total of 46 serum samples evaluated as positive by the molec-
ular approach were aliquoted and stored at −20 °C for further detection of anti-Leptospira spp. antibodies by 
MAT. Additionally, 20 negative serum samples were selected as controls. MAT was performed at the Portuguese 
Reference Laboratory for Leptospirosis (IHMT, Universidade Nova de Lisboa) using a battery of 25 live pathogenic 
serovars (including 4 Azorean isolates) representative of 15 serogroups of pathogenic Leptospira and a saprophytic 
serovar of L. biflexa as an internal control. Samples were initially screened at a 1∶40 dilution, and reactive sera were 
further diluted in a 2-fold series to the endpoint, defined as the highest serum dilution that agglutinated at least 
50% of leptospires. For the Azorean endemic region, samples were considered positive when titres were 1∶160 or 
greater, not conclusive when titres were below 1:160 (cut-off), and negative when no agglutination was observed.
Statistical analysis. The nested PCR test was used as the reference molecular test to calculate the sensi-
tivity, specificity, positive and negative predictive values (PPV and NPV), and overall accuracy [with the 95% 
confidence interval (CI)]. Calculations were performed using Vassar College’s VassarStats Website for Statistical 
Computation (http://www.vassarstats.net, last accessed May 16, 2018). To determine whether there was a signifi-
cant difference between the diagnostic tests for Leptospira detection, data were analysed by McNemar’s test and by 
Fisher Exact test, p < 0.05 indicated statistical significance. The Standards for Reporting of Diagnostic Accuracy 
(STARD) statement was followed when reporting the results of the present study25.
Data availability. All data generated or analysed during this study are included in this published article and 
the Supplementary Information files.
Results
Clinical presentation. The present work is a retrospective hospital-based study that includes samples from 
patients suspected of leptospirosis who presented mainly at the Emergency Department of the Hospital of Divino 
Espírito Santo of Ponta Delgada in São Miguel, Azores, a Portuguese island in which leptospirosis is endemic. 
A total of 202 patients were investigated from January 2015 to June 2016 (Supplementary Table S1). The mean 
patient age was 48.2 (±16.4) years. Higher rates of males (89.6%) than females (10.4%), farmers (20.3%) and 
unemployed persons (13.4%) were observed in the study population. Clinical diagnosis by the attending physi-
cian was based on signs and symptoms of leptospirosis, as previously described23,26. Briefly, physicians looked for 
epidemiological context, such as rural activities and direct contact with contaminated areas (rat urine), and clini-
cal manifestations, including fever, myalgia, jaundice and coluria, before collecting biological samples (serum and 
urine) for molecular detection/confirmation of Leptospira spp. Analysis of admission records showed that 167 
patients (82.7%) were seen at the emergency room and treated as outpatients, 18 patients (8.9%) were admitted to 
internal medicine and a7 patients (8.4%) were admitted to other departments.
qRT-PCR-HRM assay. The qRT-PCR-HRM assay was able to successfully distinguish 4 Leptospira spp. (L. 
interrogans sg Icterohaemorrhagiae, L. borgpetersenii sg Ballum, L. kirschneri sg Cynopteri and L. noguchii sg 
Panama) and the 2 human Leptospira isolates (HI1 and HI6). As shown in the derivative plot (Fig. 1), the LFB1 
F/R and G1/G2 primer sets produced distinct melting curve profiles for reference Leptospira strains of L. inter-
rogans and L. borgpetersenii spp. that matched those of the human Leptospira isolates (HI1 and HI6) of the same 
species. The Tm values obtained for LFB1 F/R were 80.71 °C (L. interrogans), 81.84 °C (L. noguchii), 82.31 °C (L. 
kirschneri) and 83.26 °C (L. borgpetersenii), and those for G1/G2 were 78.61 °C (L. noguchii), 79.10 °C (L. interro-
gans), 79.19 °C (L. kirschneri) and 81.50 °C (L. borgpetersenii). Moreover, these results were reproducible across 
10 independent melt curve runs.
qRT-PCR-HRM screening of samples from patients suspected of having leptospirosis. We 
screened 404 clinical specimens (paired serum and urine samples from 202 patients in duplicate, n = 808 sam-
ples) using qRT-PCR-HRM analysis. The average Tm with the LFB1 F/R primers was 80.94 °C in 28 (60.9%) and 
83.84 °C in 16 (39.1%) patients (Supplementary Table S2). The average Tm with the G1/G2 primers was 79.36 °C 
in 28 (60.9%) and 81.82 °C in 18 (39.1%) patients. For both primer sets, we found one clinical sample to be posi-
tive by nested PCR and negative by qRT-PCR-HRM. The Tm obtained with Leptospira spp. and the melting curve 
profile results were consistent for the remaining patient samples (Fig. 2). We clustered the melting curves in two 
groups and identified the Leptospira spp. in the patient samples by comparing the Tm values to those of the six 
Leptospira positive controls.
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Kinetics of disease progression based on Leptospira detection. We evaluated paired serum and 
urine samples from 202 patients clinically suspected of having Leptospira spp. infection by nested PCR and 
qRT-PCR-HRM (Table 1). The nested PCR results were positive for 23.3% (47/202) patients and negative for 76.7% 
(155/202). Using qRT-PCR-HRM, the results were positive for 22.7% (46/202) patients and negative for 77.2% 
(156/202). The discrepant result between the two molecular assays was confirmed to be a false positive by sequenc-
ing (see below). qRT-PCR-HRM produced conclusive results in about half of the time (~2 hr) needed to generate 
nested PCR results (usually ~5 hr). Analysis of paired samples of the 46 laboratory-confirmed cases of leptospirosis 
suggested the following kinetics of disease progression (Table 2 and Fig. 3): samples which are positive only in 
Figure 1. High resolution melting curve analysis profiles of cultured Leptospira spp., and Leptospira isolates 
from human leptospirosis patients. (a) HRM profiles using the LFB1 primer pair. (b) HRM profiles using the 
G1/G2 primer pair. Abbreviations: HI1, Human isolate 1; HI6, Human isolate 6.
Figure 2. High resolution melting curve analysis profiles of human clinical samples (serum and urine) from 
patients with suspected leptospirosis. (a) HRM profiles using the LFB1 primer pair. (b) HRM profiles using the 
G1/G2 primer pair.
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serum (urine negative) represent patients undergoing early clinical onset of infection (incubation phase, Profile 
A), samples which are positive for serum and urine represent patients undergoing early dissemination and kid-
ney colonization (early phase, Profile B) and samples which are only positive in urine (serum negative) represent 
patients that are excreting Leptospira (late phase, Profile C). A comparative analysis of these paired samples using 
both nested PCR and qRT-PCR-HRM-LFB1 primer pair showed that there is a redistribution of detection of posi-
tives between the onset and dissemination phases with nested PCR favouring dissemination (17% at onset and 61% 
at dissemination) and HRM gaining sensitivity at the onset of infection (35% at onset and 39% at dissemination). 
Differences are statistically significant by Fisher Exact test p = 0.0033. The same analysis comparing nested PCR 






Positive Negative Positive Negative Positive Negative
N % N % N % N % N % N %
Total 47 23.3 155 76.7 46 22.7 156 77.3 46 22.7 156 77.3
Duplicate samples (N = 808)
Serum
  S1 33 16.3 169 83.7 32 15.8 170 84.2 33 16.3 169 83.7
  S2 34 16.8 168 83.2 26 12.9 176 87.1 30 14.9 172 85.1
Urine
  U1 35 17.3 167 82.7 27 13.4 175 86.6 30 14.9 172 85.1
  U2 30 14.9 172 85.2 25 12.4 177 87.6 25 12.4 177 87.6
Table 1. Molecular characterization of 202 patients with suspected clinical leptospirosis. Duplicate serum and 
urine samples were investigated by conventional nested PCR and qRT-PCR-HRM methods.






Molecular profiles Phases Kinetics N % N % N % N %
Positive patients (after Sanger sequencing) 46 100 46 100 46 100 6 13.0
Profile A: Blood
(serum+/urine−) Incubation Onset 8 17.4 16 34.8 14 30.4 0 0.0
Profile B: Blood and urine
(serum+/urine+) Early
Dissemination and 
kidney colonization 28 60.9 18 39.1 22 47.8 2 4.3
Profile C: Urine
(serum-/urine+) Late Excretion 10 21.7 12 26.1 10 21.7 4 8.5
Table 2. Molecular profiles of patients with laboratory-confirmed leptospirosis and the corresponding disease 
kinetics. P > 0.05, conventional nested PCR compared with qRT-PCR-HRM; P < 0.0001, qRT-PCR-HRM 
compared with MAT.
Figure 3. Sensitivity of molecular assays in function of the kinetics of disease progression. Comparative 
analysis of positive samples by nested PCR and qRT-PCR-HRM through the three early leptospirosis stages: 
onset (serum positive), dissemination and kidney colonization (serum and urine positive) and excretion (urine 
positive). (a) Comparison with primer pair LFB1. (b) Comparison with primer pair G1/G2. Statistics by Fisher 
Exact test, A p = 0.0033 and B p = 0.0763.
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although differences in this case are not quite significant (Fisher Exact test p = 0.0763). The profile analysis also 
revealed that MAT highest percent positive was detected in the later excretion phase (serum negative and urine 
positive by molecular test) which is consistent with the kinetics of leptospirosis progression.
Sequencing analysis. To benchmark Leptospira detection by qRT-PCR-HRM analysis, we performed 
Sanger sequencing (Fig. 4). The obtained bacterial DNA sequences confirmed the positive qRT-PCR-HRM results 
in 17 clinical samples. One sample (#18) was positive in the urine by nested PCR but negative by qRT-PCR-HRM. 
This sample was assessed twice by sequencing, qRT-PCR-HRM and nested PCR, and the sequence had a 97% 
match to Collinsella aerofaciens, which is found predominantly in the human gut. For the remaining samples 
(17/18), we observed a perfect match with the reference sequences regarding Tm values, melting curve profiles, 
and sequencing data.
Microscopic agglutination test (MAT). MAT results revealed that of the 46 nested PCR-positive patients, only 
3 presented specific anti-Leptospira antibodies (6.5%), and 3 presented anti-Leptospira antibodies below the cut-off 
titre adopted by the Portuguese Reference Laboratory for Leptospirosis in the Azorean endemic region (Table 3).
Figure 4. Confirmation of the qRT-PCR-HRM analysis by Sanger sequencing. Alignment of the consensus 
sequences of the clinical samples, Leptospira spp. and human isolates. Only the sequences showing differences 
from the first sequence are shown. Nucleotides identical to those in the first sequence are indicated by dots.
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Analytical specificity and sensitivity of qRT-PCR-HRM. To validate the qRT-PCR-HRM analysis as a 
diagnostic method for Leptospira spp. detection, we assessed the accuracy parameters by comparing the results 
of nested PCR (reference molecular test) after sequencing with those obtained by qRT-PCR-HRM (Table 4). Of 
the 46 patients who were positive for leptospirosis by nested PCR, 46 had a positive qRT-PCR-HRM result, for a 
sensitivity of 1.00 (95% CI: 0.90–1.00). Moreover, of the 156 patients who were negative for leptospirosis by nested 
PCR, 156 had a negative qRT-PCR-HRM result, for a specificity of 1.00 (95% CI: 0.97–1.00). The PPV and NPV 
were 1.00 (95% CI: 0.90–1.00) and 1.00 (95% CI: 0.97–1.00), respectively. Overall, qRT-PCR-HRM accuracy was 
100%. Together, these results confirm and validate the accuracy of qRT-PCR-HRM as a clinical diagnostic test for 
human leptospirosis.
Comparison between qRT-PCR-HRM and other qRT-PCR TaqMan chemistries. The current study 
is the first to present 100% accuracy values – specificity, sensitivity, positive predictive values (PPV) and negative 
predictive values (NPV) – for a molecular PCR method, validating the qRT-PCR-HRM as the best test to be 
implemented in a clinical setting (Table 4). Compared with qRT-PCR TaqMan chemistry, qRT-PCR-HRM has the 
highest diagnostic value (accuracy, affordability and time-to-result) making this test the best to inform treatment 
decisions for hospitalized patients and patients seen in emergency rooms or clinics (Table 5).
Discussion
In this study, real-time PCR-HRM assay was validated for the accurate detection of Leptospira DNA using 202 
paired biological samples from patients presenting in the emergency room of a hospital in the Azorean island of 
São Miguel, a Portuguese region endemic for leptospirosis. Among 202 human patients suspected of having lepto-
spirosis, 46 tested positive (22.7%) by both nested PCR and qRT-PCR-HRM; among the suspected patients, only 3 
tested positive (6.5%) by MAT. Melting curve profiles with the LFB1 F/R primer set distinguished the 4 Leptospira 
spp., L. interrogans, L. borgpetersenii, L. kirschneri and L. noguchii, in cultured bacteria and human isolates (Fig. 1). 
These results are in accordance with those obtained by Naze and collegues12. In addition, template-independent 
amplifications targeting the two relevant genes (lfb1 and secY) of pathogenic Leptospira spp. also provided a 
thorough validation of the present qRT-PCR-HRM assay. The 404 human samples used – paired serum and urine 
from 202 patients, analysed in duplicated (total of 808 specimens) – validate the application of qRT-PCR-HRM as 
a clinical diagnostic test for human leptospirosis in a clinical setting.
The melting curve analysis of Leptospira species in patient samples (serum and urine) accurately discriminated 
species when positive controls were included in each run (Fig. 2). According to the Tm, the qRT-PCR-HRM assay 
Kinetics of Leptospira infection Serovar Species
Profiles
Conventional nested 
PCR (N = 46) MAT qRT-PCR-HRM
C
1 Positive (co-agglutination – highest titre 1:1280 against Arb A and Cyn) L. borgpetersenii
1 Positive (Arb A 1:160) L. borgpetersenii
1 Positive (co-agglutination – highest titre 1:320 against Arb A 1:320) L. interrogans
1 NC L. borgpetersenii
6 Negative L. interrogans
B
1 NC L. interrogans
1 NC L. interrogans
16 Negative L. interrogans
10 Negative L. borgpetersenii
A
3 Negative L. interrogans
5 Negative L. borgpetersenii
Table 3. MAT results from the 46 patients with laboratory-confirmed leptospirosis. Abbreviations: Arb 
A [serovar Arborea (Azorean isolate) serogroup Ballum]; Cyn [Cynopteri (reference serovar) serogroup 
Cynopteri]; NC, not conclusive (specific reactivity below the cut-off of 1:160 adopted in the Azorean endemic 
region).
Patients (N = 202)
qRT-PCR-HRM
Estimated value 95% CI
Sensitivity 1.00 0.90–1.00
Specificity 1.00 0.97–1.00
Positive predictive value (PPV) 1.00 0.90–1.00
Negative predictive value (NPV) 1.00 0.97–1.00
Accuracy (%) 100 —
Table 4. Diagnostic accuracy of qRT-PCR-HRM analysis compared with conventional nested PCR for 
detecting human leptospirosis infection. Abbreviation: CI, confidence interval.
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revealed that 60.9% (28/46) of patients were infected with leptospires belonging to L. interrogans, and 39.1% 
(18/46) were infected with leptospires belonging to L. borgpetersenii species (Supplementary Table S2). The most 
likely explanation for these results is that L. interrogans survives longer when exposed to the environment, which 
is why it is more prone than L. borgpetersenii to infect humans. The latter does not survive in the environment 
and is transmitted by direct contact with the host27. MAT is the hundred-year old gold standard method for the 
serodiagnosis of leptospirosis and allows for the determination of the presumptive serogroup or serovar of the 
infecting strain in routine diagnostics and/or epidemiological studies28. In the present study, MAT results sub-
stantiated the qRT-PCR-HRM findings, as these patients presented anti-Leptospira antibodies belonging to one 
of these serogroups. In addition, MAT results were positive in only 3/46 (6.5%) of the HRM-positive samples 
which is expected in recently infected febrile patients and explained by the typical delay period between time 
of infection and presence of measurable levels of antibodies in blood. Low MAT sensitivity in an early stage 
of disease infection was discussed previously29. In a clinical diagnostic context, this observation alone qualifies 
qRT-PCR-HRM as a valuable alternative to MAT by providing early unambiguous diagnosis of the disease, which 
can better inform treatment decisions by the physician as recommended by WHO30. The qRT-PCR-HRM method 
validated in the present study not only detects Leptospira in human biological samples with 100% accuracy, but 
also informs epidemiology of the disease by identifying the infecting species.
By conducting DNA sequencing as part of the assay validation, we determined that the leptospires infecting 
these patients belonged to the serogroups Icterohaemorrhagiae and Ballum (Fig. 4). These results agree with prior 
studies performed in the Azores Islands (São Miguel and Terceira), where the serogroups Icterohaemorrhagiae (L. 
interrogans) and Ballum (L. borgpetersenii) were the most frequent human23,26,31 and rodent Leptospira isolates2,32.
The profiles based on the 46 confirmed positive patients (by nested PCR and qRT-PCR-HRM) described 
in Table 2 are consistent with the kinetics of Leptospira infection and disease progression in humans3,27. The 
analysis allows us to identify the illness point at which patients presented at the hospital. Infection produces 
leptospiraemia within the first days after exposure, which is followed by the appearance of leptospires in multiple 
organs by the 3rd day of infection (incubation period and dissemination). Illness develops with the appearance 
of agglutinating antibodies 5–14 days after exposure (early phase). Leptospires are cleared from the bloodstream 
and organs in the late phase, as serum agglutinating antibody titres increase27. A higher percentage of patients in 
this study were seen in the early phase of the disease (Profile B, Table 2), when the immune system starts to pro-
duce antibodies and clearing Leptospira from the blood, which is why the bacteria is detected in serum and urine. 
Another important finding is that qRT-PCR-HRM is more sensitive than nested PCR at detecting Leptospira dur-
ing the incubation period (first seven days, Profile A, Fig. 3). This finding is of clinical relevance because it allows 
for the immediate initiation of antibiotic therapy at the earliest onset. Regarding Profile C, 23.4% of patients 
presented at the hospital when Leptospira DNA is detected in the urine. This delay in coming to the hospital 
probably occurs because the symptoms are similar to those of flu, and patients stay at home and take conventional 
over-the-counter medicine. For patients with Profile C, qRT-PCR-HRM was more specific than nested PCR; 
one patient was positive by nested PCR and negative by HRM. Bacterial DNA sequencing of this patient’s urine 
sample (#18) showed a 97% match to Collinsella aerofaciens, a type of bacteria found in the human gut, proving 
that the nested PCR result was a false positive. This finding highlights the caution necessary when interpreting 
the results of assays such as nested PCR that target the rrs gene (encoding 16S rRNA), which is conserved among 
many bacterial species, and are thus prone to cross-reactivity19. The performance of the qRT-PCR-HRM assay 
was evaluated and compared with that of the reference molecular test, nested PCR (Table 4); qRT-PCR-HRM was 
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Table 5. Comparison between qRT-PCR-HRM (SYBR) and qRT-PCR TaqMan for diagnosis of leptospirosis in 
a clinical setting. *Analysed in duplicate; NR, not reported.
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as the Azores, is highly relevant. Notably, since the nested PCR technique was implemented at HDES in 2005, 
no patient on São Miguel Island has died of leptospirosis. According to official data in the Azores (the islands of 
São Miguel and Terceira) for the period between 1986 and 2002, fewer than 19 deaths due to leptospirosis were 
reported each year31.
In clinical diagnostic laboratories, real-time PCR methods (SYBR green and TaqMan chemistries) are 
increasingly being used instead of conventional PCR methods, providing the opportunity to rapidly confirm lep-
tospirosis infection in the first days of infection. The qRT-PCR-HRM allows for accurate clinical diagnosis of lep-
tospirosis in just 2 hours, rather than the 5 hours needed for nested PCR, the results are unambiguous and easy to 
interpret and due to the use of SYBR green the costs are far below those needed for TaqMan chemistry. The HRM 
assay is a robust molecular PCR method for the diagnosis of human leptospirosis infection in endemic regions 
and it can be fully implemented in routine clinical laboratories with real-time PCR equipment. Furthermore, 
qRT-PCR-HRM has the advantage of allowing for the distinction of Leptospira species which informs leptospi-
rosis epidemiology in the geographic region without requiring the maintenance of large strain collections and 
labourious cultures. Two studies need to be highlighted as they tested several biological samples from more than 
100 patients. In Cermakova et al.22 of the 295 suspected patients tested, 5% were positive by real-time PCR. In that 
study positive samples were assigned to urine, plasma, and CSF. Although qRT-PCR-HRM was described, it is 
not clear if it was used to classify positive and negative samples. Woods et al.21 did the most comprehensive study 
to date on diagnosis of leptospirosis using real-time PCR in blood and urine samples from 778 patients. In that 
study they found that ~10% of patients were positive by rss qPCR and 2.5% were positive by the more specific 16 s 
rRNA/LipL32 qPCR, in comparison with 3.8% patients detected by MAT and 0.4% by culture. Furthermore, they 
found that serum and urine are the best samples for qPCR and that quantitative PCR on hospital admission is a 
rapid and reliable diagnostic tool that performs better than MAT or culture. Our study in the Azores substantiates 
Woods’ study in Laos, and adds the following novelty to the field: (1) only in our study a paired analysis of serum 
and urine from the same patient was done; (2) because prevalence of leptospirosis in the Azores, Portugal was 
2x to 10x higher (~23%) than Woods reports for Laos (~2.5 to ~10%) analysis of our paired samples allowed us 
to identify the illness point at which patients presented at the hospital. Another difference is that we did melting 
curve analysis which allowed us to determine that the assay is more sensitive for diagnosis of leptospirosis at the 
very early incubation phase (serum positive, urine negative) and we were able to identify the infecting species; all 
of this was done under 2 hours.
In conclusion, we did a unique comparative analysis using a robust biobank of paired samples of serum and 
urine from the same patient to validate the qRT-PCR-HRM assay for molecular diagnosis of human leptospirosis 
in a clinical setting. Furthermore, rapidly distinguishing Leptospira species while performing a rapid diagnostic 
test adds an epidemiological advantage to the assay over current clinical molecular diagnostic techniques.
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